Systematic review with meta-analysis on transplantation for alcohol-related liver disease: Very low evidence of improved outcomes

Table 3 Outcomes of included studies

Study	Transplant					No-transplant
	Abstinence length (SD or range)1	Relapse n (%)	Mortality n (%)	Loss to follow-up n (%)	Follow-up length (SD or range)1	Abstinence length (SD or range)1	Relapse n (%)	Mortality n (%)	Loss to follow-up n (%)	Follow-up length (SD or range)1
Gish et al[24]	21	6 (21)	2 (7)	0 (0)	24 (12-41)2	5	13 (93)	8 (57)	5 (36)	24 (12-41)2
Anand et al[22]	18 (6-130)	5 (13)	9 (23)	0 (0)	25 (7-63)	11 (2-86)3	27 (37)	48 (51)	11 (12)	24 (6-90)
Poynard et al[25]	≥ 64	31 (18)	56 (33)	0 (0)	28 (21-37)	NS	NS	71 (42)	NS	NS
Veldt et al[26]	≥ 6	NS	NS	NS	NS	NS	NS	NS	NS	NS
DiMartino et al[23]	NS	4 (6)	NS	NS	422	NS	13 (21)	NS	NS	422
Immordino et al[20]	NS	13 (12)5	40 (36)	NS	120	NS	5 (6)	18 (18)	14 (12)	120
Alvarez et al[21]	NS	NS	116 (70)2	9 (5)2	54 (19-96)2	NS	NS	116 (70)2	9 (5)2	54 (19-96)2
Mathurin et al[18]	NS	3 (12)	6 (23)	NS	24	NS	NS	48 (70)	NS	24
Im et al[19]	NS	2 (22)	1 (11)	NS	25 (6-39)	NS	NS	65 (76)6	NS	NS
Onishi et al[27]	21.2 (17.4)7	1 (14)	NS	NS	61.2	8.8 (13.6)	NS	NS	NS	NS

¹Median values used if both mean and median were reported and length was reported in months;

²Value is for the entire study population (both transplant and no-transplant);

³Calculated as the weighted average;

⁴All of the patients were abstinent for greater than 6 mo prior to transplant with the exception of one patient;

⁵Only 1 patient of the 8 with acute alcohol-related hepatitis relapsed;

⁶Includes 6 patients on the transplant waiting list;

⁷Includes transplant and waitlist patients. SD: Standard deviation; NS: Not specified.